Thursday, 4 June 2020

Rituximab May Hold Promise in Treating Pediatric Burkitt Lymphoma

Results of the phase III Inter-B-NHL-ritux 2010 clinical trial shows the effectiveness of Rituximab in improving the survival rate among kids with non-Hogkin lymphoma.


from Medindia Health News https://ift.tt/3gUhhY4

No comments:

Post a Comment